Publication of a Supplementary Prospectus

Cadent Finance PLC

07 April 2026

 

Publication of Supplement

7 April 2026

Cadent Finance plc (the "Issuer") announces today that it has published a supplement dated 7 April 2026 (the "Supplement") in connection with the issuance of CHF 53,000,000 1.86 per cent. Guaranteed Series 10 Notes due 14 October 2037 (the "Notes") under the £7,000,000,000 Euro Medium Term Note Programme established on 5 September 2016 for the issuance of instruments by Cadent Finance plc and unconditionally and irrevocably guaranteed by Cadent Gas Limited (the "Programme").

The Notes are expected to be admitted to trading on the International Securities Market of the London Stock Exchange on 7 April 2026.

The Supplement should be read and construed in conjunction with the Listing Particulars dated 27 November 2025 which constitute listing particulars for the purposes of UK Listing Rule 3.2.11 of the UK Listing Rules of the Financial Conduct Authority.

To view the Supplement please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/4533Z_1-2026-4-7.pdf

To view the Listing Particulars please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/3205J_1-2025-11-27.pdf

Enquiries and Investor Relations

Helena Norgate

Senior Treasury Funding Manager

Cadent

Pilot Way

Ansty

Coventry, England

CV7 9JU

Email: [e-mail]

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Listing Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Listing Particulars is not addressed. The Listing Particulars and the Supplement are not intended for use in the United States and are not addressed or targeted at U.S. persons and should not be relied upon by any U.S. person. Prior to relying on the information contained in the Listing Particulars or the Supplement, you must ascertain from the Listing Particulars and the Supplement whether or not you are one of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

 

END